- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cigars, Pipes, and Smokeless Tobacco: More Harm to the Heart Than Expected, Study Finds

USA: A new study published in JAMA Network Open sheds light on the cardiovascular risks associated with noncigarette tobacco products, such as cigars, pipes, and smokeless tobacco. The research, conducted through a cross-cohort collaboration, reveals distinct risk patterns linked to these tobacco products, highlighting significant implications for public health and the regulation of noncigarette tobacco products.
"Current cigar use was associated with a 25% higher risk of stroke, a 32% higher risk of atrial fibrillation, and a 29% higher risk of heart failure. Pipe use was linked to a 23% increased risk of heart failure and a 43% higher risk of myocardial infarction (MI). Smokeless tobacco users faced a 20% higher risk of MI and a 31% higher risk of mortality from coronary heart disease, along with elevated risks for total cardiovascular disease, heart failure, and all-cause mortality," the researchers reported.
The cardiovascular health impacts of noncigarette tobacco products, such as cigars, pipes, and smokeless tobacco, are not well understood, yet this information is crucial for informed regulatory decisions. Erfan Tasdighi, Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Baltimore, Maryland, and colleagues aimed to explore the relationship between noncigarette tobacco use and cardiovascular health outcomes.
For this purpose, the researchers conducted a cohort study as part of the Cross Cohort Collaboration Tobacco Working Group. The study harmonized tobacco-related data from 15 US-based prospective cohorts, spanning data on noncigarette tobacco use between 1948 and 2015. The analysis was performed between September 2023 and February 2024, with a median follow-up of 13.8 years for all-cause mortality outcomes.
The study focused on the current, sole, and exclusive use of noncigarette tobacco products. Sole use refers to individuals using a noncigarette tobacco product without cigarette smoking, while exclusive use means using only noncigarette tobacco and never having smoked cigarettes.
The main outcomes and measures included myocardial infarction, stroke, heart failure, atrial fibrillation, total coronary heart disease, total cardiovascular disease (CVD), coronary heart disease mortality, CVD mortality, and all-cause mortality.
The following were the key findings of the study:
- The study included 103,642 participants with an average age of 55.7 years, of which 47.8% were female and 52.2% were male.
- Current use rates were 26.3% for cigarettes, 2.1% for cigars, 1.2% for pipes, and 2.1% for smokeless tobacco.
- Current cigar use was linked to a higher risk of stroke, atrial fibrillation, and heart failure.
- Sole and exclusive cigar use was associated with an even higher risk of stroke compared to those who never used cigars or cigarettes.
- Current pipe use was connected to a higher risk of heart failure, while sole pipe use was linked to a higher risk of myocardial infarction (MI).
- Smokeless tobacco use was linked to an increased risk of coronary heart disease mortality and myocardial infarction.
- Sole and exclusive smokeless tobacco use was associated with higher risks for total cardiovascular disease (CVD), coronary heart disease, heart failure, and both cardiovascular and all-cause mortality.
"This large multicohort study is the most extensive to date on the link between cigars, pipes, smokeless tobacco, and combustible cigarettes with cardiovascular disease. Our findings suggest that using noncigarette tobacco products can cause significant harm, especially to heart health. However, the risks varied across different products, with pipes showing the smallest increase in risk," the researchers wrote.
"The insights from this study may help guide regulations on new tobacco products and set the stage for future research on emerging tobacco products," they concluded.
Reference:
Tasdighi E, Yao Z, Jha KK, et al. Cigar, Pipe, and Smokeless Tobacco Use and Cardiovascular Outcomes From Cross Cohort Collaboration. JAMA Netw Open. 2025;8(1):e2453987. doi:10.1001/jamanetworkopen.2024.53987
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751